PRELUDE THERAPEUTICS I
0.9642
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.0155
+1.63%
Today's range
0.9401 - 0.9738
ISIN
N/A
Source
NASDAQ
-
Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
04 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics to Participate at the 4th Annual Evercore ISI HealthCONx Conference
23 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update
12 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor
08 Nov 2021 09:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences
02 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update
12 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors
19 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences
02 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update
11 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Presentation at BofA Securities 2021 Virtual Health Care Conference
05 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
16 Mar 2021 08:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences
03 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
11 Jan 2021 18:20:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Pricing of Upsized Public Offering
07 Jan 2021 00:12:43 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Launch of Proposed Public Offering
04 Jan 2021 16:16:38 By Nasdaq GlobeNewswire